Compare JBLU & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JBLU | LMAT |
|---|---|---|
| Founded | 1998 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.9B |
| IPO Year | N/A | 2006 |
| Metric | JBLU | LMAT |
|---|---|---|
| Price | $4.62 | $80.40 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 9 | 6 |
| Target Price | $4.76 | ★ $101.83 |
| AVG Volume (30 Days) | ★ 16.9M | 180.5K |
| Earning Date | 01-27-2026 | 11-06-2025 |
| Dividend Yield | N/A | ★ 1.00% |
| EPS Growth | N/A | ★ 27.40 |
| EPS | N/A | ★ 2.32 |
| Revenue | ★ $9,095,000,000.00 | $240,866,000.00 |
| Revenue This Year | N/A | $15.17 |
| Revenue Next Year | $8.18 | $9.07 |
| P/E Ratio | ★ N/A | $34.56 |
| Revenue Growth | N/A | ★ 13.07 |
| 52 Week Low | $3.34 | $71.42 |
| 52 Week High | $8.31 | $105.55 |
| Indicator | JBLU | LMAT |
|---|---|---|
| Relative Strength Index (RSI) | 47.82 | 33.49 |
| Support Level | $4.50 | $83.33 |
| Resistance Level | $4.70 | $86.00 |
| Average True Range (ATR) | 0.17 | 2.17 |
| MACD | -0.05 | -0.23 |
| Stochastic Oscillator | 19.33 | 10.18 |
JetBlue Airways Corp is a low-cost airline that offers high-quality service, including assigned seating and in-flight entertainment. It served approximately 100 destinations in the United States, the Caribbean and Latin America, Canada, and England. The company currently operates Airbus A321, Airbus A320, Airbus A321neo, and Embraer E190 aircraft types. The company has one operating segment, Air Transportation Services, which provides services in the United States, the Caribbean, Latin America, Canada, and Europe. The majority of revenue is generated from the Domestic & Canada segment.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.